Gerresheimer AG (GXI.DE,GRRMF.PK) announced that it has completed a strategic review of its moulded glass business and has decided to separate the unit, with plans to initiate a sales process.
The planned divestment aligns with Gerresheimer's broader transformation into a pure-play system and solution provider for the pharma and biotech industry, focused on specialized primary packaging and drug delivery systems.
With the acquisition of Bormioli Pharma, Gerresheimer has formed a Moulded Glass Powerhouse with eight production plants across Europe, the Americas and Asia and a diversified product portfolio for the pharma, cosmetic, and food and beverage industries.
The Moulded Glass business unit generated revenues of around 735 million euros and an adjusted EBITDA margin of around 20% in 2024.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.